GlassScriptPhysician profile
Taylor M Bishop
NPI 1336855006
$720.66
in general payments reported to CMS, 2019-2025
20 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $141 · 2024: $190 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $122.18 | 2023-2025 | |
| Noven Pharmaceuticals, INC. | $88.70 | 2023 | Xelstrym |
| Novo Nordisk INC | $72.86 | 2024-2025 | Wegovy |
| Noven Therapeutics, LLC | $72.04 | 2024-2025 | Xelstrym |
| Corcept Therapeutics | $54.23 | 2025 | Korlym |
| Ibsa Pharma INC. | $40.16 | 2025 | Licart, Flector, Tirosint |
| Exact Sciences Corporation | $35.56 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Si-Bone, INC. | $29.48 | 2025 | |
| Aimmune Therapeutics, INC. | $21.45 | 2025 | Zenpep |
| Axsome Therapeutics, INC. | $21.03 | 2025 | Auvelity |
| Lilly USA, LLC | $19.76 | 2025 | Zepbound |
| Janssen Pharmaceuticals, INC | $19.62 | 2025 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $17.65 | 2025 | |
| Abiomed | $16.76 | 2024 | Impella |
| Tolmar, INC. | $16.46 | 2025 | Jatenzo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.60 | 2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $14.87 | 2025 | Breztri |
| Phadia US INC. | $14.49 | 2024 | Immunocap |
| Pfizer INC. | $14.21 | 2023 | |
| Acella Pharmaceuticals, LLC | $13.55 | 2025 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.